DEMOGRAPHIC AND SOCIOECONOMIC CHARACTERISTICS THAT IMPACT SELECTION OF ORAL ANTICOAGULANTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS

被引：1
|
作者：
Keshishian, A. [1 ]
Du, J. [1 ]
Xie, L. [1 ]
Yuce, H. [2 ,3 ]
Baser, O. [3 ,4 ]
机构：
[1] STATinMED Res, Ann Arbor, MI USA
[2] CUNY, New York City Coll Technol, New York, NY 10021 USA
[3] STATinMED Res, New York, NY USA
[4] Columbia Univ, New York, NY USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.139
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV88
引用
收藏
页码：A55 / A55
页数：1
相关论文
共 50 条
  • [41] New Anticoagulants for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation
    Hoecht, T.
    Frick, M.
    Alber, H.
    Huber, K.
    JOURNAL FUR KARDIOLOGIE, 2012, 19 (3-4): : 55 - 62
  • [42] Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation
    Manuel Cappellari
    Monica Carletti
    Alessandra Danese
    Paolo Bovi
    Journal of Thrombosis and Thrombolysis, 2016, 42 : 393 - 398
  • [43] Differences in safety and efficacy of oral anticoagulants in patients with non-valvular atrial fibrillation: A Bayesian analysis
    Sun, Zhe
    Liu, Yuqi
    Zhang, Ye
    Guo, Xinhong
    Xu, Yong
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (04)
  • [44] Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients With Non-Valvular Atrial Fibrillation and Diabetes
    Deitelzweig, Steve
    Keshishian, Allison
    Li Xiaoyan
    Dhamane, Amol
    Luo Xuemei
    Balachander, Neeraja
    Rosenblatt, Lisa
    Mardekian, Jack
    Pan Xianying
    Nadkarni, Anagha
    Di Fusco, Manuela
    Garcia, Alessandra B.
    Yuce, Huseyin
    Lip, Gregory Y.
    CIRCULATION, 2018, 138
  • [45] Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
    Yasaka, Masahiro
    Lip, Gregory Y. H.
    CIRCULATION JOURNAL, 2014, 78 (10) : 2367 - 2372
  • [46] Utilization of Oral Anticoagulants in Patients with Non Valvular Atrial Fibrillation
    Saliba, Layla
    Mondoly, Pierre
    Duparc, Alexandre
    Delay, Marc
    Maury, Philippe
    Rollin, Anne
    Calmels, Violaine
    Pathak, Atul
    Bura-Riviere, Alessandra
    Montastruc, Jean-Louis
    Bagheri, Haleh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 77 - 78
  • [47] Utilization of oral anticoagulants in patients with non valvular atrial fibrillation
    Saliba, L.
    Mondoly, P.
    Duparc, A.
    Delay, M.
    Maury, P.
    Rollin, A.
    Calmels, V.
    Pathak, A.
    Bura-Riviere, A.
    Montastruc, J. L.
    Bagheri, H.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 111 - 111
  • [48] Factors Influencing the Selection of Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation
    Park, Susin
    Je, Nam Kyung
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 26 (06) : 656 - 664
  • [49] Time to discontinuation of non-vitamin k antagonist oral anticoagulants in patients with non-valvular atrial fibrillation
    Garcia Rodriguez, L. A.
    Vora, P.
    Brobert, G.
    Lenz, Y.
    Ruigomez, A.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2958 - 2958
  • [50] Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation
    Vedovati, Maria Cristina
    Verdecchia, Paolo
    Giustozzi, Michela
    Molini, Gabriella
    Conti, Serenella
    Pierpaoli, Lucia
    Valecchi, Francesca
    Aita, Adolfo
    Agnelli, Giancarlo
    Becattini, Cecilia
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 236 : 363 - 369
12345